Main public logs
Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 09:15, 12 July 2024 JDoerfler talk contribs created page Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 (Created page with "{{Reference |Reference=Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer }} {{Study Note}} =Brief summary= Patients receiving chemotherapy often describe a decline in cognitive function (known as "chemo brain") that remains for months or years after chemotherapy has ended. As breast cancer survival rates improve, more attention is being paid to this side effect on...")
- 08:56, 12 July 2024 JDoerfler talk contribs created page Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer (Created page with "{{Publication |Title=The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer |Topic=Ginkgo |Author=Barton, DL; Burger, K; Novotny, PJ; Fitch, TR; Kohli, S; Soori, G; Wilwerding, MB; Sloan, JA; Kottschade, L.A; Rowland, KM; Dakhil, SR; Nikcevich, DA; Loprinzi, CL |Year=2013 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-012-1647-9 |Authors Abstract=Purpose Patient...")
- 07:39, 12 July 2024 JDoerfler talk contribs created page Villani et al. (2016): Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
- 07:37, 12 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Publication |Title=Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial |Topic=Vitamin E |Author=Villani, V; Zucchella, C; Cristalli, G; Galie, E; Bianco, F; Giannarelli, D; Carpano, S; Spriano, G; Pace, A |Year=2016 |Journal=Head and Neck |DOI=https://doi.org/10.1002/hed.24396 |Authors Abstract=Background. Few studies have investigated the effect of vitamin E in reducing the cisplatin (CDDP)-induced...")
- 15:25, 11 July 2024 Lbordihn talk contribs created page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial (Created page with "{{Publication |Title=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial |Topic=Frankincense (boswelia) |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors o...")
- 13:09, 11 July 2024 Lbordihn talk contribs created page Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial (Created page with "{{Reference |Reference=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial }} {{Study Note}} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysi...")
- 13:01, 11 July 2024 Lbordihn talk contribs created page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors (Created page with "{{Publication |Title=Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors |Topic=Boswellia |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors often suffer from cerebral edema and are usually treated with dexamethason...")
- 08:57, 11 July 2024 MKraft talk contribs created page Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (Created page with "{{Reference |Reference=Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies }} {{Study Note |Study Note=This is the second study of Fallon et al. (2017): Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, rando...")
- 08:54, 11 July 2024 MKraft talk contribs created page Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (Created page with "{{Reference |Reference=Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies }} {{Study Note |Study Note=This study is the first study of Fallon et al. (2017): Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind,...")
- 08:48, 11 July 2024 MKraft talk contribs created page Publication: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies (Created page with "{{Publication |Title=Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies |Topic=Cannabinoids |Author=Fallon, M T; Lux, E A; McQuade, R; Rossetti, S; Sanchez, R; Sun, W; Wright, S; Lichtman, A H; Kornyeyeva, E |Year=2017 |Journal=British Journal of Pain |DOI=https://doi.org/10.1177/2049463717710042 |Authors Abstract=Backgrou...")
- 08:12, 11 July 2024 JDoerfler talk contribs created page Upadhyaya et al. (2017): Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Reference |Reference=Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= In this study, the protective effect of vitamin E on radiotherapy-induced functional impairment of the salivary glands (auricular and submandibular salivary glands) in patients with thyroid cancer was investigated. The patients were divided into...")
- 08:01, 11 July 2024 JDoerfler talk contribs created page Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Publication |Title=Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial |Topic=Vitamin E |Author=Upadhyaya, A; Zhou, P; Meng, Z; Wang, P; Zhang, G; Jia, Q; Tan, J; Li, X; Hu, T; Liu, N; Wang, S; Liu, X; Wang, H; Zhang, C; Zhao, F; Yan, Z; Wang, X; Zhang, X; Zhang, W |Year=2017 |Journal=Nuclear Medicine Communications |DOI=https://doi.org/10.1097/MNM.0000000000000727 |Authors Abst...")
- 11:30, 10 July 2024 Cotto talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=https://doi.org/10.1016/j.ijrobp.20...")
- 11:30, 10 July 2024 Cotto talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants had a selenium deficiency at the beginning of the study. After about 7 weeks and thus the...")
- 11:22, 10 July 2024 Cotto talk contribs deleted page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= This study included 81 patients with uterine or cervical cancer. They were randomly divided into two arms and received either 500µg selenium in addition to radiotherapy or no additional preparations. All participants...", and the only contributor was "Cotto" (talk))
- 11:22, 10 July 2024 Cotto talk contribs deleted page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
- 10:06, 10 July 2024 MKraft talk contribs created page Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study (Created page with "{{Reference |Reference=Publication: Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study }} {{Study Note |Study Note=? }} =Brief summary= The study included 469 patients with different types of cancer. Randomly divided into 3 groups, one group received megestrol acetate, one group received dronabinol and one group received both drugs. After an estimated 2-3 months, there was an advanta...")
- 09:50, 10 July 2024 MKraft talk contribs created page Publication: Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study (Created page with "{{Publication |Title=Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study |Topic=Cannabinoids |Author=Jatoi, A; Windschitl, H E; Loprinzi, C L; Sloan, J A; Dakhil, S R; Mailliard, J A; Pundaleeka, S; Kardinal, C G; Fitch, T R; Krook, J E; Novotny, P J; Christensen, B |Year=2002 |Journal=Journal of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2002.20.2.567 |Authors Abstract=Purpos...")
- 14:10, 9 July 2024 JDoerfler talk contribs created page Publication: The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Publication |Title=The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial |Topic=Vitamin E |Author=Shamsaei G; Ahmadzadeh A; Mehraban N |Year=2017 |Journal=Jundishapur Journal Of Natural Pharmaceutical Products |DOI=https://doi.org/10.5812/jjnpp.65027 |Authors Abstract=Background: Chemotherapy-induced neuropathy is one of the most severe complications of cancer drug therapies causing a number of proble...")
- 14:07, 9 July 2024 JDoerfler talk contribs created page Shamsaei et al. (2017): The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Prospective |Centralized=Monocentric |Blinding=Single |Is randomized=Yes |Cross-over=No |Number of arms=2 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=70 |Analysis=ITT Analysis |Specifications on analyses=ITT not specified, but no drop-out reported. |Countries of data collectio...")
- 14:00, 9 July 2024 JDoerfler talk contribs created page Salehi et al. (2015): Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Reference |Reference=Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial }} {{Study Note}} =Brief summary= This study investigated the efficacy of vitamin E in colorectal cancer patients to alleviate chemotherapy-associated peripheral neuropathy (i.e. damage to several peripheral nerves). The intervention arm took additional vitamin E during chemotherapy and the control arm received only a placebo. The...")
- 13:50, 9 July 2024 JDoerfler talk contribs created page Publication: Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial (Created page with "{{Publication |Title=Effect of Vitamin E on Oxaliplatin-induced Peripheral neuropathy Prevention: A Randomized Controlled Trial |Topic=Vitamin E |Author=Salehi, Z; Roayaei M |Year=2015 |Journal=International Journal of preventive Medicine |DOI=https://doi.org/10.4103/2008-7802.169021 |Authors Abstract=Background: Peripheral neuropathy is one of the most important limitations of oxaliplatin base regimen, which is the standard for the treatment of colorectal cancer. Eviden...")
- 13:09, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2010): Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection for cisplatin neuropathy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instead. The results of this study are analogous to th...")
- 13:06, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection for cisplatin neuropathy (Created page with "{{Publication |Title=Vitamin E neuroprotection for cisplatin neuropathy |Topic=Vitamin E |Author=Pace, A; Giannarelli, D; Galie, E; Savarese, A; Carpano, S; Della Giulia, M; Pozzi, A; Silvani, A; Gaviani, P; Scaioli, V; Jandolo, B; Bove, L; Cognetti, F |Year=2010 |Journal=Neurology |DOI=https://doi.org/10.1212/WNL.0b013e3181d5279e |Authors Abstract=The clinical use of platinum-based antineoplastic agents is limited by severe peripheral neurotoxicity reported in up to 90%...")
- 12:06, 9 July 2024 JDoerfler talk contribs created page Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Reference |Reference=Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy }} {{Study Note}} =Brief summary= This study investigated the effect of vitamin E on the occurrence of peripheral neuropathy (i.e. damage to multiple peripheral nerves, a common side effect associated with chemotherapy). The vitamin E arm took vitamin E daily for up to one month after chemotherapy and the control arm took a placebo instea...")
- 12:02, 9 July 2024 JDoerfler talk contribs created page Publication: Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy (Created page with "{{Publication |Title=Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy |Topic=Vitamin E |Author=Pace, A; Savarese, A; Picardo, M; Maresca, V; Pacetti, U; Del Monte, G; Biroccio, A; Leonetti, C; Jandolo, B; Cognetti, F; Bove, L |Year=2003 |Journal=Journal of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2003.05.139 |Authors Abstract=Purpose: The aim of this study is to evaluate the neuroprotective effect of antioxidant...")
- 11:42, 9 July 2024 DDeel talk contribs moved page Publication Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients to Publication: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients without leaving a redirect
- 11:41, 9 July 2024 DDeel talk contribs created page Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications o...")
- 11:40, 9 July 2024 DDeel talk contribs created page Publication Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients (Created page with "{{Publication |Title=Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients |Topic=Vitamin A (beta-carotene), Vitamin E |Author=Bairati, I; Meyer, F; Jobin, E; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Têtu, B |Year=2006 |Journal=International journal of cancer |DOI=https://doi.org/10.1002/ijc.22042 |Authors Abstract=There has been concern that long-term supplementation with highdose antioxidant vitamins, especially v...")
- 09:54, 9 July 2024 DDeel talk contribs created page Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients (Created page with "{{Reference |Reference=Publication: Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Anal...")
- 09:53, 9 July 2024 DDeel talk contribs created page Publication: Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients (Created page with "{{Publication |Title=Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients |Topic=Vitamin A (beta-carotene), Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J; Têtu, B; Harel, F; Abdous, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of clinical oncology |DOI=https://doi.org/10.1200/JCO.2005.05.514 |Authors Abstract=Purp...")
- 09:44, 9 July 2024 DDeel talk contribs moved page Bairati et al. (2005): A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients to Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients without leaving a redirect
- 09:42, 9 July 2024 DDeel talk contribs deleted page Publication: A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients (content was: "{{Publication |Title=A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients |Topic=Vitamin E |Author=Bairati, I; Meyer, F; Gélinas, M; Fortin, A; Nabid, A; Brochet, F; Mercier, J. P; Têtu, B; Harel, F; Mâsse, B; Vigneault, É; Vass, S; del Vecchio, P; Roy, J |Year=2005 |Journal=Journal of the National Cancer Insti...", and the only contributor was "JDoerfler" (talk))
- 08:51, 9 July 2024 JDoerfler talk contribs deleted page TestPublication (content was: "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Jour...", and the only contributor was "Cotto" (talk))
- 08:49, 9 July 2024 JDoerfler talk contribs moved page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. to Dale, PS without leaving a redirect
- 08:41, 9 July 2024 DDeel talk contribs created page Muecke, R (Created page with "{{Author}}")
- 08:37, 9 July 2024 DDeel talk contribs created page Lippman, SM (Created page with "{{Author}}")
- 08:27, 9 July 2024 JDoerfler talk contribs created page Test author (Created blank page)
- 07:26, 9 July 2024 JDoerfler talk contribs created page Mondal et al. (2014): Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Reference |Reference=Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy }} {{Study Note}} =Brief summary= In this study, four different arms of cancer patients were examined, all of whom received chemotherapy. During chemotherapy, one arm received additional vitamin E, one arm vitamin B12, one arm glutamine and the last arm carnitine. Components of peripheral neuro...")
- 07:22, 9 July 2024 JDoerfler talk contribs created page Publication: Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy (Created page with "{{Publication |Title=Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy |Topic=Vitamin E, Carnitine, Vitamin B12 |Author=Mondal, S; Choudhury, KB; Sharma, S; Gupta, A; Dutta, S |Year=2014 |Journal=Clinical Cancer Investigation Journal |DOI=https://doi.org/10.4103/2278-0513.132113 |Authors Abstract=Context One of the major toxicities of paclitaxel is peripheral neuropathy, primar...")
- 06:28, 9 July 2024 JDoerfler talk contribs created page Mazdak et al. (2012): Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Reference |Reference=Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial }} {{Study Note}} =Brief summary= In this study, bladder cancer patients were examined with regard to the occurrence of recurrences after surgery, with half of the patients taking vitamin E daily and the other half taking nothing. There were significantly fewer recurrences in the vitamin E arm (19% vs. 36%) than in the control arm. There were no diff...")
- 06:27, 9 July 2024 JDoerfler talk contribs created page Publication: Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial (Created page with "{{Publication |Title=Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial |Topic=Vitamin E |Author=Mazdak, H; Zia, H |Year=2012 |Journal=International Journal of Preventive Medicine |DOI=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278875/ |Authors Abstract=Background Most patients with superficial bladder cancer who undergo transurethral resection of bladder tumor show recurrence of the disease. Numerous studies have explored ways to...")
- 21:15, 8 July 2024 Lbordihn talk contribs created page Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (Created page with "{{Reference |Reference=ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy }} {{Study Note}} =Brief summary= In this study, 120 patients were randomly assigned to two groups. One group received a preparation containing zeolite, while the other group received a placebo. The occurrence and severity of peripheral neuropathy due to oxaliplatin chemothe...")
- 20:30, 8 July 2024 Lbordihn talk contribs created page Publication: ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (Created page with "{{Publication |Title=ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy |Topic=Zeolites |Author=Vitale, MG; Barbato, C; Crispo, A; Habetswallner, F; De Martino, BM; Riccardi, F; Maione, A; Eisenwagen, S; Vitale, G; Cartenì, G |Year=2020 |Journal=molecules |DOI=10.3390/molecules25102297 |Authors Abstract=Chemotherapy-induced peripheral neuropat...")
- 13:38, 8 July 2024 Lbordihn talk contribs created page Vitale et al.: ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy (Created page with "{{Author}}")
- 13:32, 8 July 2024 Lbordihn talk contribs created page Vitale, MG; Barbato, C; Crispo, A; Habetswallner, F; De Martino, BM; Riccardi, F; Maione, A; Eisenwagen, S; Vitale, G; Cartenì, G (In this study, 120 patients were randomly divided into 2 groups. One group received a preparation containing zeolite, and the other group received a placebo. The occurrence and severity of peripheral neuropathy due to oxaliplatin chemotherapy were measured. After 6 months, no differences in occurrence or severity were found between the groups. Further analyses seem to find an advantage only for men, but this result must be critically viewed due to the lack of information and the failure to co...)
- 12:11, 8 July 2024 JDoerfler talk contribs created page Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Reference |Reference=Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial }} {{Study Note}} =Brief summary= This study investigated the effectiveness of vitamin E in preventing chemotherapy-induced peripheral polyneuropathy. The vitamin E arm took vitamin E twice a day in parallel with chemotherapy until one month after chemotherapy, while the control arm received only a place...")
- 11:46, 8 July 2024 JDoerfler talk contribs created page Publication: The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial (Created page with "{{Publication |Title=The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial |Topic=Vitamin E |Author=Kottschade, LA; Sloan, JA; Mazurczak, MA; Johnson, DB; Murphy, BP; Rowland, KM; Smith, DA; Berg, AR; Stella, PJ; Loprinzi, CL |Year=2011 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-010-1018-3 |Authors Abstract=Background: Chemotherapy-induced peripheral neuropathy (CIPN) co...")
- 05:15, 8 July 2024 MKraft talk contribs created page Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial (Created page with "{{Reference |Reference=Publication: Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial }} {{Study Note |Study Note=? }} =Brief summary= The study included 81 patients with different types of cancer and a history of nausea and vomiting due to chemotherapy. They were randomly divided into 2 groups, one group received THC and CBD daily and the other group a placebo. After one cycl...")
- 04:59, 8 July 2024 MKraft talk contribs created page Publication: Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial (Created page with "{{Publication |Title=Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial |Topic=Cannabinoids |Author=Grimison, P; Mersiades, A; Kirby, A; Lintzeris, N; Morton, R; Haber, P; Olver, I; Walsh, A; McGregor, I; Cheung, Y; Tognela, A; Hahn, C; Briscoe, K; Aghmesheh, M; Fox, P; Abdi, E; Clarke, S; Della-Fiorentina, S; Shannon, J; Gedye, C; Begbie, S; Simes, J; Stockler, M |Year=2020 |J...")